Apremilast for the treatment of Behcet's syndrome

Hatemi G., Yazici Y.

EXPERT OPINION ON ORPHAN DRUGS, cilt.5, sa.8, ss.677-681, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5 Sayı: 8
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/21678707.2017.1356716
  • Dergi Adı: EXPERT OPINION ON ORPHAN DRUGS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.677-681
  • İstanbul Üniversitesi Adresli: Evet

Özet

Introduction: Mucocutaneous lesions can be disabling in Behcet's syndrome patients who experience these lesions frequently and can be an important cause of impaired quality of life. Apremilast may be a safe and effective alternative for the treatment of oral and genital ulcers in Behcet's syndrome.